Nhalable Microparticles of Hydroxychloroquine for Management of Acute Respiratory Syndrome

The present invention relates to inhalable microparticles for systemic delivery. Specifically, the present invention relates to a formulation comprising inhalable microparticles of Hydroxychloroquine and surfactant. The present invention further relates to a process for preparing the formulation comprising inhalable microparticles of Hydroxychloroquine and surfactant based on quasi-emulsification solvent evaporation technique followed by freeze 10 drying. The present invention also provides a method for the management of Acute Respiratory Syndrome associated with COVID and viral morbidities comprising administering pharmaceutically effective amount of inhalable microparticles.

Inventors

Sandeep Arora, Sukhbir Singh, Neelam Sharma

Patent File Number - 202011025625        Patent File Date - 18/06/2020